Your browser doesn't support javascript.
loading
TRPC3 shapes the ER-mitochondria Ca2+ transfer characterizing tumour-promoting senescence.
Farfariello, Valerio; Gordienko, Dmitri V; Mesilmany, Lina; Touil, Yasmine; Germain, Emmanuelle; Fliniaux, Ingrid; Desruelles, Emilie; Gkika, Dimitra; Roudbaraki, Morad; Shapovalov, George; Noyer, Lucile; Lebas, Mathilde; Allart, Laurent; Zienthal-Gelus, Nathalie; Iamshanova, Oksana; Bonardi, Franck; Figeac, Martin; Laine, William; Kluza, Jerome; Marchetti, Philippe; Quesnel, Bruno; Metzger, Daniel; Bernard, David; Parys, Jan B; Lemonnier, Loïc; Prevarskaya, Natalia.
  • Farfariello V; Université de Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000, Lille, France. valerio.farfariello@inserm.fr.
  • Gordienko DV; Laboratory of Excellence, Ion Channels Science and Therapeutics, Villeneuve d'Ascq, France. valerio.farfariello@inserm.fr.
  • Mesilmany L; Université de Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000, Lille, France.
  • Touil Y; Laboratory of Excellence, Ion Channels Science and Therapeutics, Villeneuve d'Ascq, France.
  • Germain E; Université de Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000, Lille, France.
  • Fliniaux I; Laboratory of Excellence, Ion Channels Science and Therapeutics, Villeneuve d'Ascq, France.
  • Desruelles E; Laboratory of Cancer Biology and Molecular Immunology, Faculty of Sciences, Lebanese University, Hadat, Beirut, Lebanon.
  • Gkika D; Université de Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.
  • Roudbaraki M; Université de Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000, Lille, France.
  • Shapovalov G; Laboratory of Excellence, Ion Channels Science and Therapeutics, Villeneuve d'Ascq, France.
  • Noyer L; Université de Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000, Lille, France.
  • Lebas M; Laboratory of Excellence, Ion Channels Science and Therapeutics, Villeneuve d'Ascq, France.
  • Allart L; Université de Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000, Lille, France.
  • Zienthal-Gelus N; Laboratory of Excellence, Ion Channels Science and Therapeutics, Villeneuve d'Ascq, France.
  • Iamshanova O; Université de Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000, Lille, France.
  • Bonardi F; Laboratory of Excellence, Ion Channels Science and Therapeutics, Villeneuve d'Ascq, France.
  • Figeac M; Université de Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.
  • Laine W; Université de Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000, Lille, France.
  • Kluza J; Laboratory of Excellence, Ion Channels Science and Therapeutics, Villeneuve d'Ascq, France.
  • Marchetti P; Université de Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000, Lille, France.
  • Quesnel B; Laboratory of Excellence, Ion Channels Science and Therapeutics, Villeneuve d'Ascq, France.
  • Metzger D; Department of Pathology, NYU Langone Medical Center, New York City, USA.
  • Bernard D; Université de Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000, Lille, France.
  • Parys JB; Laboratory of Excellence, Ion Channels Science and Therapeutics, Villeneuve d'Ascq, France.
  • Lemonnier L; Université de Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000, Lille, France.
  • Prevarskaya N; Laboratory of Excellence, Ion Channels Science and Therapeutics, Villeneuve d'Ascq, France.
Nat Commun ; 13(1): 956, 2022 02 17.
Article en En | MEDLINE | ID: mdl-35177596
Cellular senescence is implicated in a great number of diseases including cancer. Although alterations in mitochondrial metabolism were reported as senescence drivers, the underlying mechanisms remain elusive. We report the mechanism altering mitochondrial function and OXPHOS in stress-induced senescent fibroblasts. We demonstrate that TRPC3 protein, acting as a controller of mitochondrial Ca2+ load via negative regulation of IP3 receptor-mediated Ca2+ release, is down regulated in senescence regardless of the type of senescence inducer. This remodelling promotes cytosolic/mitochondrial Ca2+ oscillations and elevates mitochondrial Ca2+ load, mitochondrial oxygen consumption rate and oxidative phosphorylation. Re-expression of TRPC3 in senescent cells diminishes mitochondrial Ca2+ load and promotes escape from OIS-induced senescence. Cellular senescence evoked by TRPC3 downregulation in stromal cells displays a proinflammatory and tumour-promoting secretome that encourages cancer epithelial cell proliferation and tumour growth in vivo. Altogether, our results unravel the mechanism contributing to pro-tumour behaviour of senescent cells.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Canales Catiónicos TRPC / Carcinogénesis / Neoplasias Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Canales Catiónicos TRPC / Carcinogénesis / Neoplasias Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article